Marker | All population | Progression | No progression | |||
---|---|---|---|---|---|---|
n = 103 | % | n = 70 | n = 33 | p | Median delay (days) | |
ESR1 | ||||||
Mutated | 22 | 21% | 22 (31%) | 0 (0%) | < 0.001 | 91 [0–282] |
Non mutated | 81 | 79% | 48 (69%) | 33 (100%) | ||
> 25% CA-15.3 increase | ||||||
Yes | 47 | 46% | 45 (64%) | 2 (6%) | < 0.001 | 0 [0–543] |
No | 56 | 54% | 25 (36%) | 31 (94%) | ||
> 100% CA-15.3 increase | ||||||
Yes | 25 | 24% | 23 (33%) | 2 (6%) | 0.003 | 0 [0–91] |
No | 78 | 76% | 47 (67%) | 31 (94%) | ||
> 25% DNA increase | ||||||
Yes | 91 | 88% | 59 (84%) | 32 (97%) | 0.1 | 182 [0–635] |
No | 12 | 12% | 11 (16%) | 1 (3%) | ||
> 100% DNA increase | ||||||
Yes | 55 | 53% | 33 (42%) | 22 (67%) | 0.1 | 92 [0–474] |
No | 48 | 47% | 37 (58%) | 11 (33%) |